To determine whether PI3K/AKT activation is clinically relevant in the pathogenesis of lymph node metastasis in ESCC, the expression level of p-AKT in ESCC tissue was determined immunohistochemically. This evidence concerns the gene AKT1 and metastatic malignant neoplasm in the lymph nodes.